Schedule 13G ownership disclosure

Cytek Biosciences Inc

Security class unavailable · CUSIP: 23285D109

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-004807
Form type
SC 13G
Filer
3E Bioventures Capital, L.P.
CIK
CIK 1911673
Filed
Feb 17, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub